Shares of Align Technology (ALGN) have gained 15.8% over the past four weeks to close the last trading session at $177.61, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $233.42 indicates a potential upside of 31.4%.The average comprises 12 short-term price targets ranging from a low of $170 to a high of $275, with a standard deviation of $31.09. While the lowest estimate indic ...

Core Viewpoint - American Well Corporation (AMWL) has seen an 11.8% increase in share price over the past four weeks, closing at $7.31, with a potential upside of 46.5% based on Wall Street analysts' mean price target of $10.71 [1][11]. Price Targets and Analyst Estimates - The mean price target is derived from seven short-term estimates with a standard deviation of $2.58, indicating variability among analysts [2]. - The lowest estimate is $7.50, suggesting a 2.6% increase, while the highest estimate predicts a surge of 105.2% to $15 [2]. - A low standard deviation signifies strong agreement among analysts regarding the stock's price direction [9]. Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about AMWL's earnings prospects, as evidenced by a positive trend in earnings estimate revisions [11]. - Over the past 30 days, one estimate has increased, leading to a 6.7% rise in the Zacks Consensus Estimate for the current year [12]. - AMWL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13].

Summit Therapeutics PLC (SMMT) closed the last trading session at $28.02, gaining 61.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $37.38 indicates a 33.4% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $5.71. While the lowest estimate of $30 indicates a 7.1% increase from the current price level, the most optimistic an ...

Shares of Apogee Therapeutics Inc. (APGE) have gained 24.1% over the past four weeks to close the last trading session at $40.12, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $93.88 indicates a potential upside of 134%.The average comprises eight short-term price targets ranging from a low of $78 to a high of $116, with a standard deviation of $11.05. While the lowest estimat ...

Core Viewpoint - Shift4 Payments (FOUR) has seen a 13.6% increase in share price over the past four weeks, closing at $82.36, with a potential upside of 41.2% based on Wall Street analysts' mean price target of $116.29 [1] Price Targets - The average of 24 short-term price targets ranges from a low of $80 to a high of $150, with a standard deviation of $16.01, indicating variability among analysts [2] - The lowest estimate suggests a decline of 2.9% from the current price, while the highest estimate indicates an upside of 82.1% [2] Analyst Sentiment - Analysts show a consensus that FOUR will report better earnings than previously estimated, which supports the expectation of a stock price increase [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 17.3%, with seven estimates moving higher and one lower [12] Zacks Rank - FOUR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]

Core Viewpoint - Alibaba (BABA) has shown a 7.9% increase in stock price over the past four weeks, with a mean price target of $158.20 indicating a potential upside of 25.8% from the current price of $125.76 [1] Price Targets and Estimates - The mean estimate consists of 20 short-term price targets with a standard deviation of $20.48, where the lowest estimate is $112 (10.9% decline) and the highest is $190 (51.1% increase) [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Analyst Sentiment and Earnings Estimates - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has increased by 1.2% over the past month, indicating positive sentiment [12] - BABA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Price targets can mislead investors, as empirical research indicates they rarely predict actual stock price movements [7] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8] - While price targets should not be ignored, they should be approached with skepticism and not be the sole basis for investment decisions [10]

Shares of Euroseas Ltd. (ESEA) have gained 18.9% over the past four weeks to close the last trading session at $32.34, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $53.67 indicates a potential upside of 66%.The mean estimate comprises three short-term price targets with a standard deviation of $8.50. While the lowest estimate of $44 indicates a 36.1% increase from the current ...

Shares of Iridium Communications (IRDM) have gained 2.4% over the past four weeks to close the last trading session at $25.17, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $38.33 indicates a potential upside of 52.3%.The mean estimate comprises six short-term price targets with a standard deviation of $7.23. While the lowest estimate of $25 indicates a 0.7% decline from the c ...

Group 1 - Oatly Group AB (OTLY) closed at $10.74, with a 20.5% gain over the past four weeks, and a mean price target of $18.31 indicating a 70.5% upside potential [1] - The mean estimate includes seven short-term price targets with a standard deviation of $10.72, ranging from a low of $10 (6.9% decline) to a high of $40 (272.4% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, with a 10.3% increase in the Zacks Consensus Estimate for the current year, indicating potential upside for the stock [11][12] Group 2 - The consensus price target is not the sole factor for investment decisions, as analysts' ability to set unbiased price targets has been questioned [3][7] - Analysts often set overly optimistic price targets due to business incentives, which can lead to inflated expectations [8] - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price movement, serving as a starting point for further research [9]

Core Viewpoint - There is significant upside potential for Veren (VRN) stock, with a mean price target of $7.99 indicating a 35% increase from the current price of $5.92 [1] Price Targets and Analyst Consensus - The average of 10 short-term price targets ranges from a low of $6.60 to a high of $9.75, with a standard deviation of $1.09, suggesting variability in analyst estimates [2] - The lowest estimate indicates an 11.5% increase, while the highest suggests a 64.7% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Market Sentiment - Analysts have shown increasing optimism about VRN's earnings prospects, as evidenced by a strong agreement in revising EPS estimates higher [11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 1.4%, with one estimate moving higher and no negative revisions [12] - VRN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set unbiased targets has been questioned [3][7] - Analysts often set overly optimistic price targets due to business incentives, which can lead to inflated estimates [8] - While price targets should not be ignored, they should be treated with skepticism and not be the sole basis for investment decisions [10]